Trial Profile
A phase I study of NC-2600 to evaluate safety and tolerability in healthy adult males.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Jan 2017
Price :
$35
*
At a glance
- Drugs NC 2600 (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions
- 27 Jan 2017 New trial record